Integrated Treatment during the Intravitreal Melphalan Era: Concurrent Intravitreal Melphalan and Systemic Chemoreduction
Author:
Publisher
S. Karger AG
Subject
General Nursing
Reference27 articles.
1. Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, Ling V, Chan HS: Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 1996; 114: 1321–1328.
2. Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ: Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114: 1348–1356.
3. Manjandavida FP, Shields CL: The role of intravitreal chemotherapy for retinoblastoma. Indian J Ophthalmol 2015; 63: 141–145.
4. Munier FL, Soliman S, Moulin AP, Gaillard MC, Balmer A, Beck-Popovic M: Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track. Br J Ophthalmol 2012; 96: 1084–1087.
5. Berry JL, Bechtold M, Shah S, Zolgaghari E, Reid M, Jubran R, Kim JW: Not all seeds are created equal: seed classification is predictive of outcomes in retinoblastoma. Ophthalmology 2017; 124: 1817–1825.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety of intravitreal chemotherapy in the management of retinoblastoma: A systematic review of the literature;Critical Reviews in Oncology/Hematology;2024-08
2. Aqueous VEGF-A Levels as a Liquid Biopsy Biomarker of Retinoblastoma Vitreous Seed Response to Therapy;Investigative Ophthalmology & Visual Science;2024-06-11
3. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma;Ophthalmology;2024-05
4. Update on chemotherapy modalities for retinoblastoma: Progress and challenges;Asia-Pacific Journal of Ophthalmology;2024-03
5. Melphalan toxicity following treatment of retinoblastoma identified by pattern electroretinogram;Ophthalmic Genetics;2022-11-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3